SCHEMBL9898252

SCHEMBL9898252

[c]1ccc(-c2nc(-c3ccccc3)c(-c3ccccc3)[nH]2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK13 O15264 11/20 0.68
▸ MAPK12 P53778 11/20 0.68
▸ MAPK11 Q15759 11/20 0.68
▸ MAPK14 Q16539 11/20 0.68
▸ RAF1 P04049 5/20 0.68
▸ MAPK9 P45984 1/20 0.68
▸ GCGR P47871 6/20 0.66
▸ NOX1 Q9Y5S8 1/20 0.60
▸ TP53 P04637 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ BRAF P15056 1/20 0.57
▸ ALOX5 P09917 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ GLA P06280 1/20 0.56
▸ GAA P10253 1/20 0.56
▸ HPGD P15428 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ MGAM O43451 1/20 0.55
▸ PTPN1 P18031 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104130 0.89 MAPK13 (0.82) MAPK13MAPK12MAPK11MAPK14RAF1
Benzene SCHEMBL28852698 0.89 MAPK13 (0.82) MAPK13MAPK12MAPK11MAPK14RAF1
Methane SCHEMBL3278320 0.87 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL27850480 0.87 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL5074753 0.87 MAPK13 (0.83) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL16667652 0.85 MAPK13 (0.83) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL739928 0.83 MAPK13 (0.72) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL2949385 0.81 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL7228717 0.81 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14514175 0.80 PTPN1 (0.73) MAPK13MAPK12MAPK11MAPK14RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9028728-B2 Photochromic materials that include indeno-fused naphthopyrans TRANSITIONS OPTICAL, INC. (US) 2015-05-12 — — US disclosed
WO-2013086248-A1 PHOTOCHROMIC MATERIALS THAT INCLUDE INDENO-FUSED NAPHTHOPYRANS PPG INDUSTRIES, INC. (US) 2013-06-13 — — WO disclosed
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans TRANSITIONS OPTICAL INC. (US) 2012-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans NQO1, INTS6, IPO4 MAPK13 1944/4885MAPK12 1838/4885MAPK11 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback